Staff Directory

Academic Qualification
- Ph.D in Pharmaceutical Technology (Medicinal Chemistry) - Doctor of Philosophy, Universiti Sains Malaysia (USM)
- Master of Science (Pharmaceutical Technology) - Masters Degree, International Islamic University Malaysia
- Chemistry - Bachelor Degree, Universiti Malaya (UM)
Mohamed Sufian Bin Mohd. Nawi (Dr.)
Assistant Professor
IIUM Kuantan Campus
KULLIYYAH OF PHARMACY
msufian@iium.edu.my
3053
Expert Profile
Mohamed Sufian bin Mohd Nawi obtained his Bachelor's degree in Chemistry from University of Malaya in 1993 and worked as a quality assurance and quality control chemist at Kekwa Indah Sdn. Bhd, Nilai Industrial Park, Malaysia. He later worked as a sales executive for scientific instruments, laboratory apparatus and chemicals for Bumi Sains Sdn. BhD.
He joined Alam Sekitar Malaysia Sdn.Bhd in 1996-2005 as a water quality monitoring officer as an area manager. He started his career as an academician in IIUM in 2008 after getting his Master's in Pharmaceutical Technology, and now he is completing his Ph.D in Pharmaceutical Technology in the field of Computer Aided Drug Design and Drug Discovery.
Mohamed Sufian is currently a lecturer at the Department of Pharmaceutical Chemistry, Kulliyyah of Pharmacy.
He joined Alam Sekitar Malaysia Sdn.Bhd in 1996-2005 as a water quality monitoring officer as an area manager. He started his career as an academician in IIUM in 2008 after getting his Master's in Pharmaceutical Technology, and now he is completing his Ph.D in Pharmaceutical Technology in the field of Computer Aided Drug Design and Drug Discovery.
Mohamed Sufian is currently a lecturer at the Department of Pharmaceutical Chemistry, Kulliyyah of Pharmacy.
Area of Specialisation
- Medical And Health ~ Medical And Health Sciences ~ Pharmacy ~ Other Pharmacy n.e.c.
Teaching Responsibilities
ANTI-INFECTIVES AGENTS | 2017/2018 2016/2017 |
BASIC PHARMACEUTICAL ANALYSIS | 2022/2023 2021/2022 2020/2021 2019/2020 |
BODY SYSTEM & THERAPEUTICS I : CARDIOVASCULAR & HAEMATOLOGY | 2022/2023 2021/2022 2020/2021 |
BODY SYSTEM I : CARDIOVACULAR & HAEMATOLOGY | 2020/2021 2019/2020 |
BODY SYSTEM II : RESPIRATORY & URINARY SYSTEM | 2017/2018 2016/2017 2015/2016 2014/2015 |
BODY SYSTEM IV: GASTROINTESTINAL &HEPATOBILIARY SYSTEMS | 2018/2019 |
BODY SYSTEM V : ENDOCRINE & REPRODUCTIVE SYSTEMS | 2018/2019 |
BODY SYSTEM VI : CNS | 2017/2018 2016/2017 2015/2016 |
COMPUTER AIDED DRUG DESIGN AND DISCOVERY | 2019/2020 2018/2019 |
COMPUTER-AIDED DRUG DESIGN AND DISCOVERY | 2021/2022 2020/2021 |
FAMILY MANAGEMENT AND PARENTING | 2019/2020 2018/2019 2017/2018 |
FINAL YEAR RESEARCH PROJECT | 2022/2023 |
FUNDAMENTALS OF MEDICINAL CHEMISTRY | 2022/2023 2021/2022 2020/2021 2019/2020 2018/2019 2017/2018 2016/2017 2015/2016 2014/2015 |
ISLAMIC INPUT IN PHARMACY | 2016/2017 |
PHARMACEUTICAL ANALYSIS I | 2018/2019 2016/2017 2015/2016 2014/2015 |
PHARMACEUTICAL ANALYSIS II | 2016/2017 2015/2016 |
PHARMACOLOGY OF PERIPHERAL NERVOUS SYSTEM | 2022/2023 2021/2022 2020/2021 |
PHARMACOLOGY OF THE PERIPHERAL NERVOUS SYSTEM | 2019/2020 2017/2018 |
Physical Pharmacy II | 2009/2010 |
RESEARCH PROJECT 1 | 2020/2021 2019/2020 2018/2019 2017/2018 2016/2017 2015/2016 |
RESEARCH PROJECT 2 | 2018/2019 2017/2018 2016/2017 |
RESEARCH PROJECT-LITERATURE SEARCH | 2020/2021 2019/2020 2018/2019 2016/2017 2015/2016 |
USRAH IN ACTION 1 | 2022/2023 |
USRAH IN ACTION 2 | 2022/2023 |
Research Projects
Completed
2020 - 2022 | BIOACTIVE COMPOUNDS IN TETRACERA SCANDENS EXTRACTS BY LC-QTOF-MS-BASED METABOLOMICS AND CORRELATION WITH XANTHINE OXIDASE ACTIVITY |
2015 - 2020 | Addressing Formulation Issues of Syariah Compliant Generic Sustained Release Antidiabetic Solid Dosage Form |
On-Going
2020 - Present | Molecular characterization and modification of 5,7,8-trihydroxyflavone and its chemical analogues to discover a novel antihyperglycemic agent |
Publications
Article
2020 | Medicinal potential of isoflavonoids: Polyphenols that may cure diabetes. Molecules, 25 () pp. |
2019 | Determination of cetirizine in human plasma and validation method using HPLC technique. Journal of Drug Delivery and Therapeutics, 9 (2-S (March-April)) pp. 243-247 |
2019 | Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling. PLoS ONE, 14 (1) pp. 1-21 |
2018 | Preliminary study on the formulation of syariah compliant generic sustained release gliclazide tablet using xanthan gum. International Medical journal Malaysia (IMJM), 17 (Special Issue 2) pp. 1-4 |
Conference or Workshop Item
2017 | Combination of xanthan gum and HPMC as retardants in sustained release gliclazide formulation. In: International Malaysian French Scientific Conference 2017, |
2016 | Ligand based drug discovery of novel dengue-2 NS2B-NS3 protease inhibitors. In: 4th International Conference on Computation for Science and Technology (ICCST 2016), |
2016 | Preliminary study on the formulation of syariah compliant generic sustained release gliclazide tablet using xanthan gum. In: 2nd World Congress on Integration and Islamicisation: Focus on Medical and Healthcare Science (2WCII 2016), |
2008 | The effect of carbopol 940 on physical stability of palm olein emulsions stabilised by span and tween surfactants. In: 8th MPS Pharmacy Scientific Conference 2008, |
2006 | Rheology of palm olein emulsions stabilized by non-ionic surfactants as potential carriers for drug delivery . In: National Seminar on Science Technology & Social Science 2006, |
Book
2017 | Palm olein emulsions potential vehicles for drug delivery. IIUM Press, International Islamic University Malaysia, ISBN: 978-967-418-700-2 |
Monograph
2018 | Addressing formulation issues of syariah compliant generic sustained release antidiabetic solid dosage form.. In: , |